Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Product sales, net $ 20,679,239 $ 11,060,636
Cost of goods sold 6,190,575 4,063,001
Gross Profit 14,488,664 6,997,635
Operating expenses:    
Selling, general and administrative (16,252,376) (13,129,950)
Research and development (724,329) (1,159,009)
Total Operating Expenses (16,976,705) (14,288,959)
Royalty buy-out (2,432,000) 0
Gain on change in derivative liability (Note 7) 248,875 147,200
Loss on extinguishment of debt (188,822) 0
Impairment of inventory (Note 3) 0 (3,562,459)
Impairment of PhytoSPHERE goodwill and intangible assets (Note 6) 0 (2,746,512)
Gain on collection of related party notes receivable 0 379,486
Total Operating Expenses (19,348,652) (20,071,244)
Operating Loss (4,859,988) (13,073,609)
Other (expense) income:    
Interest income 2 27,658
Interest expense (506,384) (1,086,793)
Other (12,269) (8,554)
Total Other Expense (518,651) (1,067,689)
Loss before income taxes benefit (5,378,639) (14,141,298)
Provision for income taxes 481,500 0
Net Loss $ (4,897,139) $ (14,141,298)
Weighted average common shares outstanding - Basic & diluted 90,512,563 52,660,749
Net loss per common share - Basic & diluted $ (0.05) $ (0.27)